Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics (Q36960609)

17 August 2017

1 reference

title

Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics (English)

1 reference

hypertrophic cardiomyopathy

17 August 2017

main subject

1 reference

3

Christine E Seidman

1 reference

17 August 2017

Ronny Alcalai

1

1 reference

17 August 2017

Jonathan G Seidman

series ordinal

2

1 reference

17 August 2017

publication date

4 October 2007

1 reference

Journal of Cardiovascular Electrophysiology

17 August 2017

published in

1 reference

17 August 2017

volume

19

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

104-110

1 reference

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

New insights into the pathology of inherited cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

The Genetic Basis for Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Sudden death in young athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Sudden death due to troponin T mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

A mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Genetics of arrhythmogenic right ventricular cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2007.00965.X

10.1111/J.1540-8167.2007.00965.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference